SMAD4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 3.51879969606728E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.05960000165817E-08 |
Normal-vs-Stage2 |
1.72060000025454E-07 |
Normal-vs-Stage3 |
1.641490E-04 |
Normal-vs-Stage4 |
2.51280000140852E-08 |
Stage1-vs-Stage2 |
4.170200E-01 |
Stage1-vs-Stage3 |
3.774600E-01 |
Stage1-vs-Stage4 |
3.413600E-02 |
Stage2-vs-Stage3 |
7.833200E-01 |
Stage2-vs-Stage4 |
1.341610E-01 |
Stage3-vs-Stage4 |
3.358600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.21989995882643E-09 |
Normal-vs-AfricanAmerican |
2.14010000054721E-07 |
Normal-vs-Asian |
3.22250000017732E-07 |
Caucasian-vs-AfricanAmerican |
9.470200E-01 |
Caucasian-vs-Asian |
1.502550E-01 |
AfricanAmerican-vs-Asian |
7.755900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.97399890772476E-11 |
Normal-vs-Female |
3.841200E-04 |
Male-vs-Female |
9.286200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
8.10010000000805E-05 |
Normal-vs-Extreme_Weight |
1.87090000158818E-08 |
Normal-vs-Obese |
1.10919999962711E-07 |
Normal-vs-Extreme_Obese |
4.242900E-03 |
Normal_Weight-vs-Extreme_Weight |
5.000000E-01 |
Normal_Weight-vs-Obese |
8.926800E-01 |
Normal_Weight-vs-Extreme_Obese |
6.678600E-01 |
Extreme_Weight-vs-Obese |
4.907600E-01 |
Extreme_Weight-vs-Extreme_Obese |
9.750200E-01 |
Obese-vs-Extreme_Obese |
6.600400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.36590000005188E-06 |
Normal-vs-Age(41-60Yrs) |
3.77500000000586E-05 |
Normal-vs-Age(61-80Yrs) |
1.16130438598816E-11 |
Normal-vs-Age(81-100Yrs) |
9.589100E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.873840E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.998800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.514600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.665970E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.573010E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.505000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
7.95669999886783E-08 |
Normal-VS-Type2 PRCC |
2.90079071874061E-12 |
Normal-VS-KIRP CIMP |
1.12649999994829E-07 |
Normal-VS-Unclassified PRCC |
3.819900E-03 |
Type1 PRCC-VS-Type2 PRCC |
1.895920E-03 |
Type1 PRCC-VS-KIRP CIMP |
1.103240E-01 |
Type1 PRCC-VS-Unclassified PRCC |
9.288200E-01 |
Type2 PRCC-VS-KIRP CIMP |
8.126000E-01 |
Type2 PRCC-VS-Unclassified PRCC |
8.732200E-02 |
KIRP CIMP-VS-Unclassified PRCC |
8.992300E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
5.75329783814027E-11 |
Normal-vs-N1 |
8.69630000011057E-07 |
Normal-vs-N2 |
4.08600000000314E-05 |
N0-vs-N1 |
8.190800E-01 |
N0-vs-N2 |
4.837600E-01 |
N1-vs-N2 |
6.007800E-01 |
|
|